Managing Pulmonary Embolism Associated With Renal Vein Thrombosis During Nephrotic Syndrome: Usefulness of Rivaroxaban Level Monitoring
Rattachement africain : it, in. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
This case report presents a scenario of pulmonary embolism (PE) and renal vein thrombosis (RVT) in a young patient with a recent diagnosis of nephrotic syndrome (NS). The presence of a clinical condition characterised by a marked non-selective proteinuria, which may correlate with reduced drug concentration, has raised doubts about the most appropriate anticoagulant therapeutic choice. A 34-year-old male patient presented to the emergency department with dyspnea, chest pain and hypotension. Two days prior, the patient had undergone a renal biopsy for a recent NS finding. An urgent CT scan revealed a right pulmonary embolism and inferior left renal vein thrombus, prompting immediate anticoagulant therapy. The patient was discharged on rivaroxaban. The presence of NS and the consequent concern regarding potential decreased drug concentration led us to monitor rivaroxaban plasma concentrations during the treatment period. Monitoring showed a strong correlation between the extent of proteinuria and the drug concentration. At the 4-month follow-up after discharge from the hospital, the patient was performing normal daily activities without limitations, and angio-CT showed complete resolution of renal and pulmonary thrombotic formations. In this clinical case, pulmonary embolism associated with renal vein thrombosis in a patient with a recent diagnosis of NS was managed with rivaroxaban with a good clinical outcome.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Managing Pulmonary Embolism Associated With Renal Vein Thrombosis During Nephrotic Syndrome: Usefulness of Rivaroxaban Level Monitoring
- Date Crossref
- 01/06/2025
- Éditeur
- Wiley
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.